NO20005145L - FremgangsmÕte for behandling av fertilitetsproblemer - Google Patents

FremgangsmÕte for behandling av fertilitetsproblemer

Info

Publication number: NO20005145L
Authority: NO; Norway
Prior art keywords: procedure; fertility problems; treating fertility; treating; antagonists
Prior art date: 1998-04-23

Application number

NO20005145A

Other languages

English (en)

Other versions

NO20005145D0 (no

NO326406B1 (no

Inventor

Juergen Engel

Hilde Riethmueller-Winzen

Thomas Reissmann

Original Assignee

Asta Medica Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-04-23

Filing date

2000-10-13

Publication date

2000-10-13

2000-10-13 Application filed by Asta Medica Ag filed Critical Asta Medica Ag

2000-10-13 Publication of NO20005145L publication Critical patent/NO20005145L/no

2000-10-13 Publication of NO20005145D0 publication Critical patent/NO20005145D0/no

2008-11-24 Publication of NO326406B1 publication Critical patent/NO326406B1/no

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/48—Reproductive organs
- A61K35/52—Sperm; Prostate; Seminal fluid; Leydig cells of testes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
- A61P5/04—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin for decreasing, blocking or antagonising the activity of the hypothalamic hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
- A61P5/08—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH for decreasing, blocking or antagonising the activity of the anterior pituitary hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/32—Antioestrogens

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Endocrinology (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Reproductive Health (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Immunology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Cell Biology (AREA)
Zoology (AREA)
Diabetes (AREA)
Biomedical Technology (AREA)
Virology (AREA)
Developmental Biology & Embryology (AREA)
Biotechnology (AREA)
Pregnancy & Childbirth (AREA)
Gynecology & Obstetrics (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Plant Substances (AREA)
Steroid Compounds (AREA)
Fats And Perfumes (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Crystals, And After-Treatments Of Crystals (AREA)
Liquid Crystal Substances (AREA)

NO20005145A 1998-04-23 2000-10-13 Anvendelse av en LHRH-antagonist for fremstilling av medikament for behandling av infertilitet. NO326406B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US8274398P	1998-04-23	1998-04-23
PCT/EP1999/002133 WO1999055357A1 (en)	1998-04-23	1999-03-29	Method for the treatment of fertility disorders

Publications (3)

Publication Number	Publication Date
NO20005145L true NO20005145L (no)	2000-10-13
NO20005145D0 NO20005145D0 (no)	2000-10-13
NO326406B1 NO326406B1 (no)	2008-11-24

Family

ID=22173160

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20005145A NO326406B1 (no)	1998-04-23	2000-10-13	Anvendelse av en LHRH-antagonist for fremstilling av medikament for behandling av infertilitet.

Country Status (24)

Country	Link
US (1)	US6319192B1 (no)
EP (1)	EP1082129B1 (no)
JP (1)	JP2002512975A (no)
KR (1)	KR100632722B1 (no)
AT (1)	ATE252910T1 (no)
AU (1)	AU752415B2 (no)
BR (1)	BR9909802A (no)
CA (1)	CA2330131C (no)
CZ (1)	CZ301912B6 (no)
DE (1)	DE69912422T2 (no)
DK (1)	DK1082129T3 (no)
ES (1)	ES2207941T3 (no)
HU (1)	HU228736B1 (no)
IL (1)	IL139027A0 (no)
NO (1)	NO326406B1 (no)
NZ (1)	NZ507405A (no)
PL (1)	PL195989B1 (no)
PT (1)	PT1082129E (no)
RU (1)	RU2221588C2 (no)
SI (1)	SI1082129T1 (no)
SK (1)	SK285192B6 (no)
TR (1)	TR200003063T2 (no)
UA (1)	UA66850C2 (no)
WO (1)	WO1999055357A1 (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6828415B2 (en) *	1993-02-19	2004-12-07	Zentaris Gmbh	Oligopeptide lyophilisate, their preparation and use
EP0788799A3 (en) *	1996-02-07	1998-10-21	ASTA Medica Aktiengesellschaft	LHRH-Antagonists in the treatment of fertility disorders
US8173592B1 (en) *	1999-03-31	2012-05-08	Zentaris Ivf Gmbh	Method for a programmed controlled ovarian stimulation protocol
US6758806B2 (en)	2001-01-12	2004-07-06	Napoli, Llc	Endoscopic devices and method of use
US20060183973A1 (en) *	2001-01-12	2006-08-17	Kamrava Michael M	Endoscopic devices and method of use
US6623422B2 (en) *	2001-01-12	2003-09-23	Napoli, Llc	Method and apparatus for assisted embryo implantation
US8465412B2 (en) *	2001-01-12	2013-06-18	Michael Levy	Uterine devices and method of use
DE60222735T2 (de) *	2001-01-12	2008-07-17	Napoli, LLC, Beverly Hills	Intrauterin-Mikrokatheter
EP1463493B1 (en) *	2001-12-14	2007-10-03	Laboratoires Serono SA	Methods of inducing ovulation-using a non-polypeptide camp level modulator
US7033314B2 (en) *	2002-01-11	2006-04-25	Fidelitycorp Limited	Endoscopic devices and method of use
US20030186892A1 (en) *	2002-03-28	2003-10-02	Rajneesh Taneja	Enhancement of endogenous gonadotropin production
US6695766B2 (en)	2002-04-26	2004-02-24	Olympia Womens Health	Magnetic embryo transfer
EP1364658A1 (en) *	2002-05-24	2003-11-26	Applied Research Systems ARS Holding N.V.	Use of varying ratios of gonadotrophins in controlled ovarian hyperstimulation
AU2003274929B2 (en) *	2002-06-07	2008-04-10	Ares Trading S.A.	Method of controlled ovarian hyperstimulation and pharmaceutical kit for use in such method

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5130137A (en) *	1989-08-09	1992-07-14	The General Hospital Corporation	Continuous delivery of luteinizing hormone releasing hormone compositions in combination with sex steroid delivery for use in treating benign ovarian secretory disorders
DE4305225A1 (de)	1993-02-19	1994-08-25	Asta Medica Ag	Neues Herstellverfahren für Cetrorelix Lyophilisat
DE19604231A1 (de) *	1996-01-29	1997-07-31	Schering Ag	Pharmazeutisches Kombinationspräparat und seine Verwendung zur Behandlung von gynäkologischen Störungen
EP0788799A3 (en) *	1996-02-07	1998-10-21	ASTA Medica Aktiengesellschaft	LHRH-Antagonists in the treatment of fertility disorders
US5824548A (en) *	1996-05-29	1998-10-20	Wisconsin Alumni Research Foundation	Method of increasing survival of cultured primate embryos in medium containing exogenous gonadotrophin releasor hormone
DE19712718C2 (de) *	1997-03-26	1999-09-23	Asta Medica Ag	Immobilisierte und aktivitätsstabilisierte Komplexe von LHRH-Antagonisten und Verfahren zu deren Herstellung
US5961444A (en) *	1997-10-17	1999-10-05	Medworks Corporation	In vitro fertilization procedure using direct vision

1999
- 1999-03-29 NZ NZ507405A patent/NZ507405A/xx not_active IP Right Cessation
- 1999-03-29 PT PT99919152T patent/PT1082129E/pt unknown
- 1999-03-29 WO PCT/EP1999/002133 patent/WO1999055357A1/en active IP Right Grant
- 1999-03-29 HU HU0101528A patent/HU228736B1/hu unknown
- 1999-03-29 DE DE69912422T patent/DE69912422T2/de not_active Expired - Lifetime
- 1999-03-29 EP EP99919152A patent/EP1082129B1/en not_active Expired - Lifetime
- 1999-03-29 ES ES99919152T patent/ES2207941T3/es not_active Expired - Lifetime
- 1999-03-29 AU AU37028/99A patent/AU752415B2/en not_active Expired
- 1999-03-29 DK DK99919152T patent/DK1082129T3/da active
- 1999-03-29 CA CA2330131A patent/CA2330131C/en not_active Expired - Lifetime
- 1999-03-29 SK SK1530-2000A patent/SK285192B6/sk not_active IP Right Cessation
- 1999-03-29 UA UA2000116510A patent/UA66850C2/uk unknown
- 1999-03-29 BR BR9909802-4A patent/BR9909802A/pt not_active Application Discontinuation
- 1999-03-29 IL IL13902799A patent/IL139027A0/xx not_active IP Right Cessation
- 1999-03-29 PL PL99343609A patent/PL195989B1/pl unknown
- 1999-03-29 JP JP2000545555A patent/JP2002512975A/ja active Pending
- 1999-03-29 CZ CZ20003766A patent/CZ301912B6/cs not_active IP Right Cessation
- 1999-03-29 KR KR1020007011649A patent/KR100632722B1/ko not_active IP Right Cessation
- 1999-03-29 AT AT99919152T patent/ATE252910T1/de active
- 1999-03-29 RU RU2000129658/14A patent/RU2221588C2/ru active
- 1999-03-29 TR TR2000/03063T patent/TR200003063T2/xx unknown
- 1999-03-29 SI SI9930448T patent/SI1082129T1/xx unknown
- 1999-04-23 US US09/296,610 patent/US6319192B1/en not_active Expired - Lifetime
2000
- 2000-10-13 NO NO20005145A patent/NO326406B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
EP1082129A1 (en)	2001-03-14
EP1082129B1 (en)	2003-10-29
TR200003063T2 (tr)	2001-02-21
DK1082129T3 (da)	2004-01-26
SI1082129T1 (en)	2004-02-29
JP2002512975A (ja)	2002-05-08
ES2207941T3 (es)	2004-06-01
NZ507405A (en)	2002-10-25
CA2330131C (en)	2011-10-25
KR100632722B1 (ko)	2006-10-16
ATE252910T1 (de)	2003-11-15
AU752415B2 (en)	2002-09-19
RU2221588C2 (ru)	2004-01-20
CA2330131A1 (en)	1999-11-04
HUP0101528A3 (en)	2001-12-28
DE69912422D1 (de)	2003-12-04
BR9909802A (pt)	2000-12-26
NO20005145D0 (no)	2000-10-13
NO326406B1 (no)	2008-11-24
PT1082129E (pt)	2004-03-31
HU228736B1 (en)	2013-05-28
CZ20003766A3 (cs)	2001-08-15
SK15302000A3 (sk)	2001-10-08
SK285192B6 (sk)	2006-08-03
HUP0101528A2 (hu)	2001-11-28
PL343609A1 (en)	2001-08-27
UA66850C2 (uk)	2004-06-15
US6319192B1 (en)	2001-11-20
PL195989B1 (pl)	2007-11-30
IL139027A0 (en)	2001-11-25
DE69912422T2 (de)	2004-08-19
CZ301912B6 (cs)	2010-07-28
KR20010042873A (ko)	2001-05-25
WO1999055357A1 (en)	1999-11-04
AU3702899A (en)	1999-11-16

Publication	Publication Date	Title
NO20005145L (no)	2000-10-13	FremgangsmÕte for behandling av fertilitetsproblemer
ATE215081T1 (de)	2002-04-15	Gonadotropin releasing hormon- antagonisten
FI963036A (fi)	1996-08-01	Munasarjan estrogeenista riippuvaisten tilojen hoito
NZ325060A (en)	2000-02-28	Non peptide indole derivative and their use as antagonists of gonadotropin releasing hormone
MX9804850A (es)	1998-09-30	Antagonistas de hormona liberadora de gonadotropina.
ATE183198T1 (de)	1999-08-15	Immunogens gegen gonadotropin releasing hormone
MXPA04004364A (es)	2004-08-11	Composiciones para el tratamiento de disfuncion sexual femenina postmenopausica.
CY1105931T1 (el)	2011-04-06	Χρηση ενος αγωνιστη/ανταγωνιστη οιστρογονου για την αντιμετωπιση γυναικειας σεξουαλικης δυσλειτουργιας
FI963049A (fi)	1996-10-01	Progesteroniantagonisteja lääkeaineiden valmistamiseksi, jotka on tarkoitettu kohdun toimintahäiriöistä johtuvien verenvuotojen hoitamiseksi
BG101553A (en)	1998-09-30	Progesterone antagonist and antiestrogenous active compounds of general application for female contraceptives
PT1066304E (pt)	2005-06-30	Antagonistas macrolidos de lhrh
WO2002056903A3 (en)	2003-10-30	Methods for treating hormone associated conditions using a combination of lhrh antagonists and specific estrogen receptor modulators
NZ506622A (en)	2003-03-28	3',3'-N-bis-substituted macrolide LHRH antagonists
ATE8988T1 (de)	1984-09-15	Lh-rh antagonisten.
WO2001021194A3 (en)	2002-03-14	Method for the therapeutic management of endometriosis and fallopian tube obstruction
GR900100489A (el)	1991-11-15	Συνθέσεις χρήσιμοι ως αντισυλληπτικά για άνδρες.
BRPI0409571A (pt)	2006-04-18	métodos e kits para a manutenção de gravidez, tratamento de cistos foliculares, e sincronização da ovulação empregando-se hormÈnio de luteinização
Schally	1970	Hypothalamic regulation of FSH and LH secretion
EP0268066A3 (en)	1990-07-11	Fertility control and uterine therapy in dogs with luteinizing hormone releasing hormone antagonists
MX9707008A (es)	1997-11-29	Uso de antiestrogenos para control natal en hombres.

Legal Events

Date	Code	Title	Description
2019-04-08	MK1K	Patent expired